J Biomed Sci October 2019 PMID 31629410

Tumor-associated macrophages: an accomplice in solid tumor progression.

Yibing Chen, Yucen Song, Wei Du, Longlong Gong, Haocai Chang, Zhengzhi Zou

Mentions

34
Peak: 25 in Oct 2023
across 3 sources since Nov 2021

Extended reach

353,276
potential audience

Total likes

275

Video views

50

Mentions per month

Nov 2021 – Aug 2025

Where it's discussed

  • X / Twitter30 posts
  • YouTube2 videos
  • News2 articles

AI synopsis

What people are saying

The overall tone suggests a cautious recognition of the role of tumor-associated macrophages in cancer progression, with comments referencing industry developments such as biotech partnerships and pathways, like Macrophages and NK+M, indicating some engagement with translational or therapeutic implications. The language and references point to moderate interest but limited deep engagement with the core scientific findings.

AgreementLow agreement

The discussions reflect some skepticism about the immediate impact or application of the research, with little explicit support or disagreement.

InterestModerate interest

Participants show moderate interest, particularly around related therapeutic strategies and industry developments, but some posts are more tangential.

EngagementNeutral engagement

The exchanges seem somewhat superficial, mainly referencing other sources or broad concepts without deep analysis.

ImpactNeutral impact

The posts indicate awareness of the research's potential relevance but do not suggest it is causing significant shifts in thinking or practice yet.

Abstract in brief

  • Tumor-associated macrophages (TAMs) are key players in the tumor microenvironment and are linked to poorer survival rates in patients with solid tumors.
  • TAMs originate from immune cells and their behavior is influenced by the tumor microenvironment, which can cause them to support tumor growth, resistance to treatments, and metastasis through processes like promoting blood vessel formation and suppressing the immune response.
  • Therapeutic approaches targeting TAMs include methods to eliminate or inhibit their activity, boost their ability to attack cancer cells, and prevent monocyte recruitment, aiming to improve treatment outcomes for solid tumor patients.]

Top posts

Most liked on X and Bluesky
Яizal do
@afrkml · X

Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp https://t.co/nPeP77VmWn https://t.co/Qxw2QT0FbV https://t.co/AkZYzrG5Sz https://t.co/nwYSHR68ku https://t.co/Z4mafPZa2m

Oct 2, 2023 · 272 likes · 48 shares · 343,218 followers View post →
LagunaRay
@Long6422Da · X

@ANACONDAFINANC1 @RNA_Biotech Prob no near term takeout given CEO "driver's seat" stated in Jeff webcast in answer tol afm13 partnerships question and not enough afm24 data til late next year. $tril got taken out for cd47/macrophages pathway. $afmd begets NK+M combo https://t.co/gqJHnE0N4r

Nov 19, 2021 · 2 likes · 1 share · 55 followers View post →
ayna
@JustMention8 · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Jul 12, 2025 · 48 shares · 1,810 followers View post →
Bowo_merden
@mbanyu79 · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Oct 3, 2023 · 48 shares · 1,452 followers View post →
Aaaaaaaa s°krim ½ anget
@anaknyaDaddyJ · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Oct 2, 2023 · 48 shares · 869 followers View post →
Ester Irene
@ester_irene · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Oct 4, 2023 · 48 shares · 529 followers View post →

All mentions

Chan
@my_moonlight221 · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Aug 16, 2025 · 48 shares · 402 followers View post →
ayna
@JustMention8 · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Jul 12, 2025 · 48 shares · 1,810 followers View post →
@mbrocia...next level.....
@AndriSusan81661 · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Feb 8, 2025 · 48 shares · 106 followers View post →
Noname
@maila_shofa · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Oct 8, 2023 · 48 shares · 111 followers View post →
Die✨
@dir4ni · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Oct 4, 2023 · 48 shares · 40 followers View post →
kmp
@paramithatika · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Oct 4, 2023 · 48 shares · 448 followers View post →
Ester Irene
@ester_irene · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Oct 4, 2023 · 48 shares · 529 followers View post →
CK
@chkalstri · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Oct 4, 2023 · 47 shares · 13 followers View post →
T
@T_ayank · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Oct 3, 2023 · 48 shares · 41 followers View post →
namericanoww
@jmyochinn · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Oct 3, 2023 · 48 shares · 12 followers View post →
Sabilla
@Sabillahell · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Oct 3, 2023 · 48 shares · 5 followers View post →
ranger kuning
@yellow_ranger14 · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Oct 3, 2023 · 48 shares · 1 followers View post →
V
@satorudsrraa · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Oct 3, 2023 · 48 shares · 32 followers View post →
inimaee
@youngladymee · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Oct 3, 2023 · 48 shares · 41 followers View post →
Bowo_merden
@mbanyu79 · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Oct 3, 2023 · 48 shares · 1,452 followers View post →
ᴀᴋᴜᴏʀᴀᴜʀᴜꜱ⁷
@mosthensem · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Oct 2, 2023 · 48 shares · 309 followers View post →
Elent HD
@Nekareanemesis · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Oct 2, 2023 · 48 shares · 187 followers View post →
Novnav
@Novnav21 · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Oct 2, 2023 · 48 shares · 6 followers View post →
Leta。
@mewwleta · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Oct 2, 2023 · 48 shares · 329 followers View post →
Zoi Nugroho
@Utamizoe · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Oct 2, 2023 · 48 shares · 13 followers View post →
Irvan
@irvanwahyuuu_ · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Oct 2, 2023 · 48 shares · 38 followers View post →
Aaaaaaaa s°krim ½ anget
@anaknyaDaddyJ · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Oct 2, 2023 · 48 shares · 869 followers View post →
lontong sayur
@gengenandrian · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Oct 2, 2023 · 48 shares · 3 followers View post →
Doremi
@Doitifuhappy · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Oct 2, 2023 · 48 shares · 164 followers View post →
Sri Wahyuni
@sri_wahyuni35 · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Oct 2, 2023 · 48 shares · 125 followers View post →
pangilencaaja
@Ncasalted · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Oct 2, 2023 · 48 shares · 8 followers View post →
Woelan Achmad
@WoelanAchmad · X

RT @afrkml: Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp ht…

Oct 2, 2023 · 48 shares · 134 followers View post →
Яizal do
@afrkml · X

Daftar bacaan tambahan: https://t.co/DPOMLycPEV https://t.co/tYOWwOBBCo https://t.co/g7heyNtD4N https://t.co/U7epChImdp https://t.co/nPeP77VmWn https://t.co/Qxw2QT0FbV https://t.co/AkZYzrG5Sz https://t.co/nwYSHR68ku https://t.co/Z4mafPZa2m

Oct 2, 2023 · 272 likes · 48 shares · 343,218 followers View post →
Seyyed gharibzada
@SeyyedMassoud12 · X

RT @Long6422Da: @ANACONDAFINANC1 @RNA_Biotech Prob no near term takeout given CEO "driver's seat" stated in Jeff webcast in answer tol afm1…

Nov 20, 2021 · 1 share · 36 followers View post →
LagunaRay
@Long6422Da · X

@ANACONDAFINANC1 @RNA_Biotech Prob no near term takeout given CEO "driver's seat" stated in Jeff webcast in answer tol afm13 partnerships question and not enough afm24 data til late next year. $tril got taken out for cd47/macrophages pathway. $afmd begets NK+M combo https://t.co/gqJHnE0N4r

Nov 19, 2021 · 2 likes · 1 share · 55 followers View post →